US Food and Drug Administration and design of drug approval studies
JAMA
.
2014 Nov 26;312(20):2163-5.
doi: 10.1001/jama.2014.13329.
Authors
Steven Woloshin
1
,
Lisa M Schwartz
1
,
Brittney Frankel
2
,
Adrienne Faerber
1
Affiliations
1
Center for Medicine and the Media, The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire.
2
Cornell-Weill Medical School, New York, New York.
PMID:
25423223
DOI:
10.1001/jama.2014.13329
No abstract available
MeSH terms
Clinical Protocols
Clinical Trials as Topic
Communication
Drug Approval / methods*
Drug Industry*
Research Design
United States
United States Food and Drug Administration*